HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prevention And Science Trends Driving Double-Digit Growth In APAC Prebiotics Market

Executive Summary

“For consumers around the globe, and the APAC market is a prime example, there is an ongoing shift from reactivity to proactivity,” explains Clasado Biosciences David Mharakurwa. Alongside an increasing awareness of the links between gut health and wellness, such trends are driving strong growth in the region for nutraceuticals like Clasado’s Bimuno GOS. 

You may also be interested in...

Clasado Begins European Expansion Of Bimuno Prebiotic With Italy And San Marino

Prebiotic manufacturer Clasado has struck a deal to bring its Bimuno brand to Europe's most liberal biotics market, Italy, as well as neighboring San Marino. It's the first move in an international expansion strategy which will eventually take Clasado to the US and Asia.

Probiotics For COVID-19? Research Points To Possible Gut-Lung Immune Axis

A recent randomised clinical trial found a four-strain cocktail of probiotics sped up recovery from COVID-19, as well as from related symptoms. Academics at a university in London, UK, suggest this is evidence of the "gut-lung immune axis."

Could The Gut Cure Brain Disease?

Scientists now understand that there are multiple, bi-directional links between gut and brain. They are using this knowledge to develop new treatments for some of the most challenging chronic conditions, including Alzheimer’s disease, Parkinson’s disease and obesity. 


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts